Cognition Therapeutics Stock Forecast

Hold candidate since Jul 13, 2026

The Cognition Therapeutics, Inc. stock price fell by -6.42% on the last day (Monday, 13th Jul 2026) from $1.09 to $1.02. During the last trading day the stock fluctuated 10.20% from a day low at $0.98 to a day high of $1.08. The price has fallen in 5 of the last 10 days and is down by -8.93% for this period. Volume has increased on the last day by 975 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 million shares were bought and sold for approximately $2.56 million.

The stock is at the lower part of a very wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $1.02 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect Cognition Therapeutics, Inc. stock with a 90% probability to be traded between $1.01 and $1.67 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

CGTX Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, June 24, 2026, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Cognition Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.08 and $1.22. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Cognition Therapeutics, Inc. stock

Cognition Therapeutics, Inc. finds support from accumulated volume at $0.98 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.100 between high and low, or 10.20%. For the last week, the stock has had daily average volatility of 8.32%.

Cognition Therapeutics, Inc. is oversold on RSI14 (21). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: $0.96 (-5.58%) (This stock has very high daily movements and this gives very high risk. Low RSI14 is 21 which reduces the risk some. There is a buy signal from a pivot bottom found 12 days ago.)

Trading Expectations (CGTX) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Cognition Therapeutics, Inc. to open at $1.03, and during the day (based on 14 day Average True Range), to move between $0.95 and $1.09, which gives a possible trading interval of +/-$0.131 (+/-13.76%) up or down from last closing price. If Cognition Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 13.76% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.98 (4.37%) than the resistance at $1.09 (6.86%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Cognition Therapeutics, Inc. stock A Buy?

Cognition Therapeutics, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.699 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $1.03 ( 0.654%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk